MXPA03008588A - Nuevos derivados de pirimidin-2,4,6-triona, procedimiento para su produccion y agentes farmaceuticos que contienen estos compuestos. - Google Patents
Nuevos derivados de pirimidin-2,4,6-triona, procedimiento para su produccion y agentes farmaceuticos que contienen estos compuestos.Info
- Publication number
- MXPA03008588A MXPA03008588A MXPA03008588A MXPA03008588A MXPA03008588A MX PA03008588 A MXPA03008588 A MX PA03008588A MX PA03008588 A MXPA03008588 A MX PA03008588A MX PA03008588 A MXPA03008588 A MX PA03008588A MX PA03008588 A MXPA03008588 A MX PA03008588A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- processes
- production
- pharmaceutical agents
- agents containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01107714 | 2001-03-30 | ||
| PCT/EP2002/003366 WO2002079170A2 (en) | 2001-03-30 | 2002-03-26 | Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03008588A true MXPA03008588A (es) | 2003-12-08 |
Family
ID=8176973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03008588A MXPA03008588A (es) | 2001-03-30 | 2002-03-26 | Nuevos derivados de pirimidin-2,4,6-triona, procedimiento para su produccion y agentes farmaceuticos que contienen estos compuestos. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6716845B2 (es) |
| EP (1) | EP1383746A2 (es) |
| JP (1) | JP2004533425A (es) |
| KR (1) | KR20030086335A (es) |
| CN (1) | CN1273454C (es) |
| AR (1) | AR035800A1 (es) |
| AU (1) | AU2002302470C1 (es) |
| BR (1) | BR0208440A (es) |
| CA (1) | CA2442354A1 (es) |
| MX (1) | MXPA03008588A (es) |
| PA (1) | PA8542001A1 (es) |
| PE (1) | PE20021101A1 (es) |
| UY (1) | UY27239A1 (es) |
| WO (1) | WO2002079170A2 (es) |
| ZA (1) | ZA200306615B (es) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4595700A (en) | 1984-12-21 | 1986-06-17 | G. D. Searle & Co. | Thiol based collagenase inhibitors |
| GB8726714D0 (en) | 1987-11-14 | 1987-12-16 | Beecham Group Plc | Compounds |
| GB8827305D0 (en) | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| US5239078A (en) | 1990-11-21 | 1993-08-24 | Glycomed Incorporated | Matrix metalloprotease inhibitors |
| AU652596B2 (en) | 1990-12-03 | 1994-09-01 | Celltech Limited | Peptidyl derivatives |
| CA2058797A1 (en) | 1991-02-01 | 1992-08-02 | Michael John Broadhurst | Amino acid derivatives |
| US5789434A (en) | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
| CZ292942B6 (cs) | 1995-12-08 | 2004-01-14 | Agouron Pharmaceuticals, Inc. | Derivát (N-hydroxykarbamoyl)-1-(4-fenoxy)benzensulfonylu |
| DE19548624A1 (de) | 1995-12-23 | 1997-06-26 | Boehringer Mannheim Gmbh | Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19726427A1 (de) * | 1997-06-23 | 1998-12-24 | Boehringer Mannheim Gmbh | Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US6350786B1 (en) | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| CO5210860A1 (es) | 1999-10-01 | 2002-10-30 | Hoffmann La Roche | Nuevos derivados de pirimidina-2,4,6-triona |
-
2002
- 2002-02-25 US US10/082,907 patent/US6716845B2/en not_active Expired - Fee Related
- 2002-03-26 BR BR0208440-6A patent/BR0208440A/pt not_active IP Right Cessation
- 2002-03-26 KR KR10-2003-7012814A patent/KR20030086335A/ko not_active Application Discontinuation
- 2002-03-26 AU AU2002302470A patent/AU2002302470C1/en not_active Ceased
- 2002-03-26 CN CNB028074912A patent/CN1273454C/zh not_active Expired - Fee Related
- 2002-03-26 EP EP02730063A patent/EP1383746A2/en not_active Withdrawn
- 2002-03-26 JP JP2002577797A patent/JP2004533425A/ja active Pending
- 2002-03-26 MX MXPA03008588A patent/MXPA03008588A/es active IP Right Grant
- 2002-03-26 CA CA002442354A patent/CA2442354A1/en not_active Abandoned
- 2002-03-26 PE PE2002000242A patent/PE20021101A1/es not_active Application Discontinuation
- 2002-03-26 WO PCT/EP2002/003366 patent/WO2002079170A2/en active Application Filing
- 2002-03-27 AR ARP020101143A patent/AR035800A1/es unknown
- 2002-03-27 UY UY27239A patent/UY27239A1/es not_active Application Discontinuation
- 2002-03-27 PA PA20028542001A patent/PA8542001A1/es unknown
-
2003
- 2003-08-25 ZA ZA200306615A patent/ZA200306615B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002079170A3 (en) | 2003-11-27 |
| CN1553901A (zh) | 2004-12-08 |
| AR035800A1 (es) | 2004-07-14 |
| ZA200306615B (en) | 2004-11-25 |
| BR0208440A (pt) | 2004-03-30 |
| PA8542001A1 (es) | 2002-10-28 |
| PE20021101A1 (es) | 2003-02-13 |
| JP2004533425A (ja) | 2004-11-04 |
| US6716845B2 (en) | 2004-04-06 |
| CN1273454C (zh) | 2006-09-06 |
| AU2002302470B2 (en) | 2008-02-14 |
| KR20030086335A (ko) | 2003-11-07 |
| UY27239A1 (es) | 2002-09-30 |
| AU2002302470C1 (en) | 2008-07-24 |
| CA2442354A1 (en) | 2002-10-10 |
| US20020187991A1 (en) | 2002-12-12 |
| WO2002079170A2 (en) | 2002-10-10 |
| EP1383746A2 (en) | 2004-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0303148A3 (en) | 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation | |
| MXPA03005018A (es) | Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos, y su uso. | |
| MXPA03005019A (es) | Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos y su uso. | |
| MXPA03000873A (es) | Derivados de quinazolina, medicamentos que contienen estos compuestos, su uso y metodos para la produccion de los mismos. | |
| HUP0203766A3 (en) | 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them | |
| ZA200107989B (en) | 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof. | |
| IL158784A (en) | Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| HUP0401346A3 (en) | Hiv inhibiting pyrimidines derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0301852A3 (en) | Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof | |
| IL166710A0 (en) | Process for the preparation of 4-ÄÄ4-ÄÄ-(2-cyanoethenyl)2,6-dimethylphenylÜaminoÜ-2-pyrimidinylÜaminoÜbenzonitrile | |
| AU2002219173A1 (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use | |
| HUP0201122A2 (en) | Pyrimidinone compounds, process for their preparation and pharmaceutical compositions containing them | |
| IL150225A0 (en) | Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof | |
| ZA985406B (en) | Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical preparations containing these compounds. | |
| HUP0401638A3 (en) | Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same | |
| HUP0400155A3 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
| MXPA03007635A (es) | P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen. | |
| ZA200102589B (en) | Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof. | |
| IL161428A0 (en) | Oligoamine derivatives, methods for the production thereof and pharmaceutical compositions containing the same | |
| HUP0303155A3 (en) | 2-thio-substituted imidazole derivatives, the use thereof and pharmaceutical compositions containing them | |
| IL148573A0 (en) | New pyrimidine -2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds | |
| HUP0303045A3 (en) | Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| ZA200305877B (en) | Novel pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof. | |
| HUP0200928A2 (hu) | Pirido-tieno-diazepinek, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények | |
| IL162188A0 (en) | Process for the preparation of Ä1,4,5Ü-oxadiazepine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |